So I think that's an area of strength for us." The Wegovy GLP-1 pill by Novo Nordisk (NVO) approved by regulators last December arrived at pharmacies nationwide in early January
Ko YH, Jeong M, Jang DS, Choi JH
Cardones and Grichnik
Harmony Outcomes committees and investigators
Digestive Disturbances Many users report gastrointestinal side effects, including: Nausea Vomiting Constipation Diarrhea Bloating These symptoms may be dismissed as normal, but they can interfere with nutrient absorption, gut health, and overall quality of life
In the phase 2 NEJM trial, participants receiving the highest dose of retatrutide (12 mg) achieved a mean body weight reduction of approximately 24.2% from baseline at 48 weeks, compared with approximately 2.1% in the placebo group